Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 7 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CAD
The 5 analysts offering 12 month price targets for Oncolytics Biotech Inc have a median target of 6.80, with a high estimate of 9.00 and a low estimate of 3.50. The median estimate represents a 427.13% increase from the last price of 1.29.
High | 597.7% | 9.00 |
Med | 427.1% | 6.80 |
Low | 171.3% | 3.50 |
Earnings history & estimates in CAD
The next earnings announcement is expected on Nov 01, 2024.
Average growth rate | -10.87% |
Average growth rate | +17.30% |
More ▼
Revenue history & estimates in CAD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼